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Abstract. Fluorescence spectroscopy is a technology used fruitfully for biomedical diagnostics as well as for ther-
apeutic purposes. The fluorescent analysis method are applied in biomedical diagnostics based on fluorescence of
endogenous or exogenous fluorophores. We initially applied fluorescence spectroscopy for the study of human liver
cancer (hepatocellular carcinoma) with an exogenous fluorophores, Radachlorinr 0.35%. The main aim of this study
is to determine the spectral variation between normal and malignant liver tissues in 2 cases: the samples exposed and
non-exposed to Radachlorin. The excitation wavelength used for the fluorescence measurements is 405 nm.
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I. INTRODUCTION
Liver cancer is the third most common cause of cancer-deaths after lung, stomach cancers.
Liver cancer in males occurs more common than in females. Development of early detection
methods plays an important role in therapy and has great influence on therapeutic effect.
The exploration of new methods and techniques for the diagnosis of tumors has been de-
veloped quickly in the recent years. Optical spectroscopy is one of these methods which have
many advantages such as simple, rapid, non-invasive,... The measurement of fluorescence from
tissue has become a clinical diagnostic tool, especially to assess tissue malignancy or tissue func-
tion. The underlying physical basis is that they are strongly influenced by cellular structure and
chemical composition of the tissues [1, 2].
Morphological and biochemical changes in a diseased tissue cause the fluorophores inside
the tissue to fluoresce differently. Due to its sensitivity to minute variations, fluorescence spec-
troscopy can provide both qualitative and quantitative biochemical information about the state of
the tissue, which may not be obtained by using standard pathology. In the recent past, its di-
agnostic potential has been tested in different organs of the body, including the mouth, breast,
esophagus, and bladder, etc. The fact that the tissue is a complex medium, the intrinsic spectra is
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substantially modified by the medium before its detection. Both characteristic and statistical fea-
tures of the spectra can reflect the nature and condition of the tissue. In fluorescence spectroscopy,
the fluorophores are active under excitation of the ultraviolet and visible light to be useful identi-
fiers [2–4].
Biological tissue contains numerous endogenous fluorophores such as flavins, nucleotides
(NADH), tryptophan, tyrosine, elastin, collagen etc. Tissue autofluorescence can be used to help
characterise the tissue components and provide contrast between different types and states of tis-
sue. For example in cancers of epithelial origin there is a greater contribution to the surface
autofluorescence from NADH (due to an increased of number of metabolically active cells) and a
reduced contribution from collagen (due to thickening of the mucosal layer pushing the collagen-
rich sub-mucosal layer further away from the tissue surface) [2, 5].
Besides autofluorescence due to endogenous fluorophores, a large number of exogenous
fluorophores (photosensitizer) have been created and studied as well to be used for biological
diagnostics. These fluorophores have been created for many different purposes and applications in
the field of biological monitoring such as monitoring cellular function using fluorescent reporter
dyes or molecules for various biochemical species.
The aim of this study is to determine the spectral variation between normal and malignant
liver tissues in 2 cases: the samples exposed and non-exposed to photosensitizer, Radachlorinr
0.35%.
II. METHODS AND MATERIALS
Photosensitizer
The Radachlorinr was purchased from the RADA-PHARMA group (RADA-PHARMA
Co, Ltd., Moscow, Russia), which was stable in solutions at 0 ± 8oC in the dark. Radachlorinr
was diluted with distilled water at ratio of 1: 15. Radachlorin fluoresces from the wavelength of
646 nm to the wavelength of 680 nm [6, 7].
Biological samples
Diseased human liver (hepatocellular carcinoma) which cut out of a patient was soaked in
formaldehyde solution 10%. The liver samples contained both the areas of normal and malignant
tissues were cut into thin slices of 0.5 mm. Fig. 1 is an image of the diseased liver cut out of
patient.
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Fig. 1. Hepatocellular carcinoma in human.
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These samples were divided into two groups: Radachlorin exposed group (group 1) and
Radachlorin non-exposed group (group 2).
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Fig. 2. Hepatocellular carcinoma sample was cut from human liver.
Radachlorin uptake by liver samples
Biological samples of group 2 were soaked in Radachlorin in 24 hours at room temperature.
After a predetermined time, the Radachlorin solution was discarded from the surface of samples:
the samples were washed three times with distilled water. Then they were put in a cuvette. Fig. 2
shows a hepatocellular carcinoma sample cut into a thin slice 0.5 mm and put in the cuvette.
Measurement of tissue samples
Fluorescence spectra were measured by fluorescence spectrophotometer Varian Cary Eclipse
(Australia) with an excitation wavelength at 405 nm (corresponds to the absorption due to endoge-
nous fluorophore, porphyrin). The cuvette contains the tissue sample is placed in the sample holder
in the instrument. The schematic diagram of the instrument is shown in Fig. 3 [8].
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Fig 3. Schematic diagram of the basic fluorescence spectrophotometer. 
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Fig 4. Fluorescence spectra of Radachlorin 
non-exposed tissue samples (group 1) excited 
at wavelength of 405nm  
Fig 5. Normalized fluorescence spectra of 
Radachlorin exposed tissue samples (group 2) 
excited at wavelength of 405nm.  
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Fig. 3. Schematic diagram of the basic fluorescence spectrophotometer.
Each sample was measured at three different areas: malignant area, normal area and bound-
ary between normal and malignant area.
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from the normal area to the malignant area. The intensity value at the malignant area is highest
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Fig. 4. Fluorescence spectra of Radachlorin non-
exposed tissue samples (group 1) excited at wave-
length of 405 nm.
Fig. 5. Normalized fluorescence spectra of
Radachlorin exposed tissue sa ples (group 2) ex-
cited at wavelength of 405 nm.
Fig. 5 shows the difference in the intensity value between the normal and the malignant
tissue area becomes clearer when the tissue sample is exposed to photosensitizer (group 2). When
the tissue sample is exposed to Radachlorin solution and excited at a wavelength of 405 nm,
the fluorescence spectra have 2 peaks at 677 nm and 715 nm. In this case, we can see that the
difference of the height of spectrum peaks of the areas is relatively clear. The height of spectrum
peak gradually decreases from the malignant area to the normal area.
IV. CONCLUSIONS
The fluorescence emission spectroscopic technique was employed for the qualitative spec-
tral analysis of hepatocellular carcinoma in human liver. The fluorescence measurements were
carried out at 405 nm excitation wavelength, which corresponds to the absorption due to endoge-
nous fluorophore, on all the two sample groups. The results show that the intensity value between
the malignant tissue area and the normal tissue area is different. This value gradually decreases
from the malignant area to the normal area. The difference of value intensity in photosensitizer
exposed case is clearer than that in photosensitizer non-exposed case. This result is very helpful
in diagnosing cancer.
However, this is only the initial results. In the next time, we will carry out more experiments
to affirm that it is possible to use diagnostic techniques based on fluorescence spectroscopy to early
diagnose cancer.
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